This document provides guidelines for the prevention, detection, evaluation, and treatment of high blood pressure. Key points include:
1) For those over 50, systolic blood pressure over 140 mm Hg is a greater risk factor than diastolic blood pressure.
2) Risk of cardiovascular disease doubles with each 20/10 mm Hg increase in blood pressure, starting at 115/75 mm Hg.
3) Those with a systolic pressure of 120-139 mm Hg or diastolic of 80-89 mm Hg should be considered prehypertensive and lifestyle changes are recommended to prevent cardiovascular disease.
4) Most patients will require two or more blood pressure medications to reach a goal blood pressure of 140
Clinical guidelines were developed through a consensus process involving 25 experts to provide evidence-based recommendations for managing nonvariceal upper gastrointestinal bleeding. The guidelines emphasize initial patient resuscitation and clinical risk stratification to determine the need for early endoscopy. For low-risk patients, endoscopy can allow safe early discharge. For high-risk patients, endoscopic hemostasis is recommended. The guidelines also make recommendations regarding H. pylori testing and eradication, as well as the use of proton pump inhibitors after endoscopic therapy. Future research is still needed to evaluate newer endoscopic therapies and optimal medical management.
The document provides guidelines for the management of thyrotoxicosis from the American Thyroid Association and American Association of Clinical Endocrinologists task force. It includes 100 evidence-based recommendations on topics such as the initial evaluation and diagnosis of thyrotoxicosis, management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery, and management of toxic multinodular goiter or toxic adenoma. The task force developed the recommendations based on a systematic review of the literature and expert consensus using a standardized grading system for strength of recommendations and quality of evidence.
The document summarizes the work of the Nicaraguan Institute for Land Studies (INETER) in using GIS and monitoring systems to study natural hazards in Nicaragua. It describes INETER's roles in seismic, volcanic, tsunami and landslide monitoring. It also discusses the development of GIS systems and hazard maps to improve disaster prevention, response and land management. The use of GIS is still developing within INETER and greater training, data sharing and hardware/software resources are needed to strengthen monitoring and disaster risk reduction efforts.
DESIGNING WEB-ENABLED SERVICES TO PROVIDE DAMAGE ESTIMATION MAPS CAUSED BY NA...Vladimir Gutierrez, PhD
The document describes designing a web-enabled service to provide damage estimation maps caused by natural hazards. It discusses:
1) The need for standardized maps with detailed damage information after natural disasters.
2) Related work including global tools like PAGER and GEM that estimate earthquake impacts.
3) A case study in Nicaragua using resources like building inventories, hazard maps, and risk/loss software to estimate earthquake damage in Managua.
4) A methodology connecting these resources through OGC standards and services, as well as a system architecture for processing data and generating warnings.
The document discusses various ultrasound screening programs that can check for issues in important organs and vascular systems. Screenings described include those for the thyroid gland, carotid arteries, heart, bone density, liver, spleen, gallbladder, kidneys, peripheral artery disease, abdominal aortic aneurysm, metabolism, and arterial elasticity. The screenings identify potential cysts, masses, blockages, and other irregularities. Scheduling and costs are also covered.
Clinical guidelines were developed through a consensus process involving 25 experts to provide evidence-based recommendations for managing nonvariceal upper gastrointestinal bleeding. The guidelines emphasize initial patient resuscitation and clinical risk stratification to determine the need for early endoscopy. For low-risk patients, endoscopy can allow safe early discharge. For high-risk patients, endoscopic hemostasis is recommended. The guidelines also make recommendations regarding H. pylori testing and eradication, as well as the use of proton pump inhibitors after endoscopic therapy. Future research is still needed to evaluate newer endoscopic therapies and optimal medical management.
The document provides guidelines for the management of thyrotoxicosis from the American Thyroid Association and American Association of Clinical Endocrinologists task force. It includes 100 evidence-based recommendations on topics such as the initial evaluation and diagnosis of thyrotoxicosis, management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery, and management of toxic multinodular goiter or toxic adenoma. The task force developed the recommendations based on a systematic review of the literature and expert consensus using a standardized grading system for strength of recommendations and quality of evidence.
The document summarizes the work of the Nicaraguan Institute for Land Studies (INETER) in using GIS and monitoring systems to study natural hazards in Nicaragua. It describes INETER's roles in seismic, volcanic, tsunami and landslide monitoring. It also discusses the development of GIS systems and hazard maps to improve disaster prevention, response and land management. The use of GIS is still developing within INETER and greater training, data sharing and hardware/software resources are needed to strengthen monitoring and disaster risk reduction efforts.
DESIGNING WEB-ENABLED SERVICES TO PROVIDE DAMAGE ESTIMATION MAPS CAUSED BY NA...Vladimir Gutierrez, PhD
The document describes designing a web-enabled service to provide damage estimation maps caused by natural hazards. It discusses:
1) The need for standardized maps with detailed damage information after natural disasters.
2) Related work including global tools like PAGER and GEM that estimate earthquake impacts.
3) A case study in Nicaragua using resources like building inventories, hazard maps, and risk/loss software to estimate earthquake damage in Managua.
4) A methodology connecting these resources through OGC standards and services, as well as a system architecture for processing data and generating warnings.
The document discusses various ultrasound screening programs that can check for issues in important organs and vascular systems. Screenings described include those for the thyroid gland, carotid arteries, heart, bone density, liver, spleen, gallbladder, kidneys, peripheral artery disease, abdominal aortic aneurysm, metabolism, and arterial elasticity. The screenings identify potential cysts, masses, blockages, and other irregularities. Scheduling and costs are also covered.
Strataderm - scar treatment and prevention with siliconeLuka Valas
Strataderm is a rapidly drying silicone gel for treatment and prevention of scars. It softens and flattens scars, relieves itching and discomfort of scars, reduces redness and discoloration. More info: www.strataderm.com
twitter.com/strataderm
VEB presentation to Sec. of Commerce and Trade Jim Cheng, Governor McDonnell’s Senior Economic Advisor Bob Sledd, Assistant Secretary for Policy Carrie Cantrell and Jimmy Rhee, Assistant Secretary for International Development Tuesday, April 6, 2010
Virginia Economic Bridge is a nonprofit organization that promotes economic development in Virginia. It works to bring together business leaders and regions across the state through partnerships and initiatives. It provides services like research, marketing, and helping attract and retain businesses and jobs. One Care of Southwest Virginia is focused on reducing substance abuse in the region through coalition building, advocacy, and data analysis. It has a board of directors and partners with other organizations to address this issue. Both organizations aim to improve the economy and address issues in their regions of Virginia through collaboration.
The document summarizes the agenda and goals of the Virginia Economic Bridge (VEB) Regional Board of Directors meeting. VEB is a nonprofit organization that promotes economic development in Virginia through partnerships between different regions. Its mission is to advocate for shared economic development visions and partnerships between Southwest Virginia, Northern Virginia, and other parts of the state. The meeting aimed to discuss VEB messaging, recruitment, retention programs, and board recruitment to help Virginia meet future business and workforce challenges.
Lt. Governor Bill Bolling spoke at a meeting in Richmond, Virginia on April 5, 2010 about Virginia Economic Bridge (VEB), a nonprofit organization that promotes economic development in Virginia. VEB works to bring together business leaders across regions of Virginia to build partnerships and address issues like workforce development, infrastructure, and ensuring Virginia is prepared to meet future business and economic challenges. VEB conducts research, marketing, and facilitates information sharing across regions through websites and programs aimed at recruitment, retention, and job creation.
The CPA of the (not too distant) future looks different that today’s CPA. Tax preparation is not a core CPA service. Increased specialization and collaboration among specialists will be necessary to service clients and work on internal organizational issues. Scared yet? Get yourself ready for this change through a glimpse of how the CPA profession is expected to evolve as we share with you the results of the AICPA’s CPA Horizons 2025 research study and key insights from thought leaders in the profession.
This document summarizes the mission and activities of Virginia Economic Bridge, Inc., a nonprofit organization that promotes economic development in Virginia. It provides an overview of the organization's staff, mission to connect different regions of Virginia, programs related to workforce development, business opportunities, and information portals. Key programs and services mentioned include Return to Roots, Linked Workforce Initiative, Virginia Business Pipeline, and data and research services.
The document summarizes the agenda and discussions at the annual spring Board of Directors meeting of Virginia Economic Bridge, Inc. The agenda included remarks from special guests, approval of previous meeting minutes, financial reports, and discussions around strategic goals and initiatives for 2011. Key topics of discussion were rebranding the organization, developing economic stimulus and business development initiatives to connect companies in Northern Virginia with opportunities in Southwest Virginia, and legislative issues impacting economic development and job creation in the state.
This document provides an update to guidelines for diagnosing, evaluating, and treating high blood pressure in children and adolescents. Key points include:
- New data from NHANES 1999-2000 were added to childhood blood pressure norms. Guidelines were revised based on this new data.
- Hypertension is now defined as average blood pressure at or above the 95th percentile. Blood pressure between the 90th and 95th percentile is termed "prehypertensive."
- Factors like proper cuff size, measurement technique, and repeat measurements are important for accurate blood pressure readings in children.
- Evidence of early organ damage from hypertension in children provides rationale for early identification and treatment. Treatment recommendations were updated based
Circulation 2015-criterios de jones reviewgisa_legal
This document revises the Jones criteria for diagnosing acute rheumatic fever to better align with current evidence and international guidelines. It recognizes that acute rheumatic fever remains a serious health problem globally. The revisions define high-risk populations, acknowledge variability in clinical presentation among these groups, and include Doppler echocardiography as a tool for diagnosing cardiac involvement even without overt symptoms. This represents the first major revision to the Jones criteria by the American Heart Association in over 20 years and applies their classification system for recommendations and evidence levels.
Circulation 2015-criterios de jones reviewgisa_legal
This document revises the Jones criteria for diagnosing acute rheumatic fever to better align with current evidence and international guidelines. It recognizes that acute rheumatic fever remains a serious health problem globally. The revisions define high-risk populations, acknowledge variability in clinical presentation among these groups, and include Doppler echocardiography as a tool for diagnosing cardiac involvement even without overt symptoms. This represents the first major revision to the Jones criteria by the American Heart Association in over 20 years and applies their classification system for recommendations and evidence levels.
Nada Alkis' Master Thesis, Novo Nordisk & University of CopenhagenNada Alkis
My master thesis consisted of two parts. The first part is based on the research question: Are the FDA and EMA aligned in their approval decisions regarding fixed dose combination (FDC) medical products? This question was explored by evaluating the labels of all the FDCs approved between: January 2000 – April 2017 within 5 chronic therapeutic areas: type-2 diabetes mellitus (T2DM), asthma, chronic obstructive pulmonary disease (COPD), hypertension, and human immunodeficiency virus (HIV). In fact, it was found that there were differences between the FDA and EMA approval decisions with regards to the approved and used in pre-defined sub-populations. Some of the reasons for these discrepancies are discussed.
The second part of this thesis attempts to apply for the conceptual issues addressed in the first part to a practical setting. Specifically, assessing the real-world patient reported outcomes (PROs) for patients switched to a certain FDC product, Xultophy. And how the PROs collected from this real-world use might compare to the clinical trial PROs used to support labelling claims. It was found that real-world data, in the form of PROs collected in a community pharmacy setting, is a novel and interesting approach to gathering important information and could be explored further in future research.
This document provides guidelines for evaluating patients with pulmonary nodules from the American College of Chest Physicians. It summarizes the guideline objectives, target population, diagnostic and management interventions considered, major outcomes, methodology, recommendations, and validation process. The guideline was developed through a systematic review of literature and expert consensus to provide evidence-based recommendations. It defines solitary pulmonary nodules and provides 12 major recommendations on pre-test probability assessment, imaging tests, PET scanning, discussion of risks/benefits with patients, and tissue diagnosis.
Cardiorenal Syndrome Classification, Pathophysiology, Diagnosis, and Treatmen...pedro betancourt
This document provides a scientific statement on cardiorenal syndrome from the American Heart Association. It defines cardiorenal syndrome as disorders involving dysfunction of both the heart and kidneys, where acute or chronic dysfunction in one organ can induce dysfunction in the other. The statement describes the classification of cardiorenal syndrome into five subtypes based on the organ of initial injury and disease acuity. It discusses the pathophysiology, diagnostic strategies, and therapeutic options for cardiorenal syndrome. The goal is to provide guidance to cardiologists and nephrologists on the management of this important condition.
1. The document provides clinical guidelines for managing patients with nonvariceal upper gastrointestinal bleeding based on a consensus of experts.
2. Key recommendations include developing institution-specific protocols for multidisciplinary management including early endoscopy. Patients should be risk stratified into low- and high-risk categories based on clinical and endoscopic criteria to determine management and likelihood of rebleeding or death.
3. For high-risk patients, endoscopic hemostatic therapy within 24 hours of presentation is recommended while low-risk patients can often be safely discharged without endoscopy. Ongoing research is still needed to refine treatment protocols.
This document provides a critique of the ACCF/AHA Scientific Statement on Syncope. It was submitted by a consortium of over 60 physicians with expertise in transient loss of consciousness. The consortium has concerns that the Scientific Statement fails to adequately address long-standing clinical errors in syncope evaluation, provides imprecise definitions, omits important recent literature, and does not present the evaluation of syncope in full clinical context. If not revised, the Scientific Statement risks promoting inadequate patient care and potentially harmful legal standards for physicians.
International consensus recommendations on the management of 2010Klauditha AC
This document provides an update to international consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding (UGIB). A multidisciplinary group of 34 experts developed the recommendations using a standardized process. Key recommendations include:
1) Early risk stratification of patients using validated prognostic scales to identify high-risk cases requiring intervention.
2) Performing early endoscopy (within 24 hours) for risk assessment and therapeutic purposes.
3) Using endoscopic hemostasis for high-risk lesions while considering attempts to dislodge clots for underlying stigmata using pharmacological or combination treatments.
Strataderm - scar treatment and prevention with siliconeLuka Valas
Strataderm is a rapidly drying silicone gel for treatment and prevention of scars. It softens and flattens scars, relieves itching and discomfort of scars, reduces redness and discoloration. More info: www.strataderm.com
twitter.com/strataderm
VEB presentation to Sec. of Commerce and Trade Jim Cheng, Governor McDonnell’s Senior Economic Advisor Bob Sledd, Assistant Secretary for Policy Carrie Cantrell and Jimmy Rhee, Assistant Secretary for International Development Tuesday, April 6, 2010
Virginia Economic Bridge is a nonprofit organization that promotes economic development in Virginia. It works to bring together business leaders and regions across the state through partnerships and initiatives. It provides services like research, marketing, and helping attract and retain businesses and jobs. One Care of Southwest Virginia is focused on reducing substance abuse in the region through coalition building, advocacy, and data analysis. It has a board of directors and partners with other organizations to address this issue. Both organizations aim to improve the economy and address issues in their regions of Virginia through collaboration.
The document summarizes the agenda and goals of the Virginia Economic Bridge (VEB) Regional Board of Directors meeting. VEB is a nonprofit organization that promotes economic development in Virginia through partnerships between different regions. Its mission is to advocate for shared economic development visions and partnerships between Southwest Virginia, Northern Virginia, and other parts of the state. The meeting aimed to discuss VEB messaging, recruitment, retention programs, and board recruitment to help Virginia meet future business and workforce challenges.
Lt. Governor Bill Bolling spoke at a meeting in Richmond, Virginia on April 5, 2010 about Virginia Economic Bridge (VEB), a nonprofit organization that promotes economic development in Virginia. VEB works to bring together business leaders across regions of Virginia to build partnerships and address issues like workforce development, infrastructure, and ensuring Virginia is prepared to meet future business and economic challenges. VEB conducts research, marketing, and facilitates information sharing across regions through websites and programs aimed at recruitment, retention, and job creation.
The CPA of the (not too distant) future looks different that today’s CPA. Tax preparation is not a core CPA service. Increased specialization and collaboration among specialists will be necessary to service clients and work on internal organizational issues. Scared yet? Get yourself ready for this change through a glimpse of how the CPA profession is expected to evolve as we share with you the results of the AICPA’s CPA Horizons 2025 research study and key insights from thought leaders in the profession.
This document summarizes the mission and activities of Virginia Economic Bridge, Inc., a nonprofit organization that promotes economic development in Virginia. It provides an overview of the organization's staff, mission to connect different regions of Virginia, programs related to workforce development, business opportunities, and information portals. Key programs and services mentioned include Return to Roots, Linked Workforce Initiative, Virginia Business Pipeline, and data and research services.
The document summarizes the agenda and discussions at the annual spring Board of Directors meeting of Virginia Economic Bridge, Inc. The agenda included remarks from special guests, approval of previous meeting minutes, financial reports, and discussions around strategic goals and initiatives for 2011. Key topics of discussion were rebranding the organization, developing economic stimulus and business development initiatives to connect companies in Northern Virginia with opportunities in Southwest Virginia, and legislative issues impacting economic development and job creation in the state.
This document provides an update to guidelines for diagnosing, evaluating, and treating high blood pressure in children and adolescents. Key points include:
- New data from NHANES 1999-2000 were added to childhood blood pressure norms. Guidelines were revised based on this new data.
- Hypertension is now defined as average blood pressure at or above the 95th percentile. Blood pressure between the 90th and 95th percentile is termed "prehypertensive."
- Factors like proper cuff size, measurement technique, and repeat measurements are important for accurate blood pressure readings in children.
- Evidence of early organ damage from hypertension in children provides rationale for early identification and treatment. Treatment recommendations were updated based
Circulation 2015-criterios de jones reviewgisa_legal
This document revises the Jones criteria for diagnosing acute rheumatic fever to better align with current evidence and international guidelines. It recognizes that acute rheumatic fever remains a serious health problem globally. The revisions define high-risk populations, acknowledge variability in clinical presentation among these groups, and include Doppler echocardiography as a tool for diagnosing cardiac involvement even without overt symptoms. This represents the first major revision to the Jones criteria by the American Heart Association in over 20 years and applies their classification system for recommendations and evidence levels.
Circulation 2015-criterios de jones reviewgisa_legal
This document revises the Jones criteria for diagnosing acute rheumatic fever to better align with current evidence and international guidelines. It recognizes that acute rheumatic fever remains a serious health problem globally. The revisions define high-risk populations, acknowledge variability in clinical presentation among these groups, and include Doppler echocardiography as a tool for diagnosing cardiac involvement even without overt symptoms. This represents the first major revision to the Jones criteria by the American Heart Association in over 20 years and applies their classification system for recommendations and evidence levels.
Nada Alkis' Master Thesis, Novo Nordisk & University of CopenhagenNada Alkis
My master thesis consisted of two parts. The first part is based on the research question: Are the FDA and EMA aligned in their approval decisions regarding fixed dose combination (FDC) medical products? This question was explored by evaluating the labels of all the FDCs approved between: January 2000 – April 2017 within 5 chronic therapeutic areas: type-2 diabetes mellitus (T2DM), asthma, chronic obstructive pulmonary disease (COPD), hypertension, and human immunodeficiency virus (HIV). In fact, it was found that there were differences between the FDA and EMA approval decisions with regards to the approved and used in pre-defined sub-populations. Some of the reasons for these discrepancies are discussed.
The second part of this thesis attempts to apply for the conceptual issues addressed in the first part to a practical setting. Specifically, assessing the real-world patient reported outcomes (PROs) for patients switched to a certain FDC product, Xultophy. And how the PROs collected from this real-world use might compare to the clinical trial PROs used to support labelling claims. It was found that real-world data, in the form of PROs collected in a community pharmacy setting, is a novel and interesting approach to gathering important information and could be explored further in future research.
This document provides guidelines for evaluating patients with pulmonary nodules from the American College of Chest Physicians. It summarizes the guideline objectives, target population, diagnostic and management interventions considered, major outcomes, methodology, recommendations, and validation process. The guideline was developed through a systematic review of literature and expert consensus to provide evidence-based recommendations. It defines solitary pulmonary nodules and provides 12 major recommendations on pre-test probability assessment, imaging tests, PET scanning, discussion of risks/benefits with patients, and tissue diagnosis.
Cardiorenal Syndrome Classification, Pathophysiology, Diagnosis, and Treatmen...pedro betancourt
This document provides a scientific statement on cardiorenal syndrome from the American Heart Association. It defines cardiorenal syndrome as disorders involving dysfunction of both the heart and kidneys, where acute or chronic dysfunction in one organ can induce dysfunction in the other. The statement describes the classification of cardiorenal syndrome into five subtypes based on the organ of initial injury and disease acuity. It discusses the pathophysiology, diagnostic strategies, and therapeutic options for cardiorenal syndrome. The goal is to provide guidance to cardiologists and nephrologists on the management of this important condition.
1. The document provides clinical guidelines for managing patients with nonvariceal upper gastrointestinal bleeding based on a consensus of experts.
2. Key recommendations include developing institution-specific protocols for multidisciplinary management including early endoscopy. Patients should be risk stratified into low- and high-risk categories based on clinical and endoscopic criteria to determine management and likelihood of rebleeding or death.
3. For high-risk patients, endoscopic hemostatic therapy within 24 hours of presentation is recommended while low-risk patients can often be safely discharged without endoscopy. Ongoing research is still needed to refine treatment protocols.
This document provides a critique of the ACCF/AHA Scientific Statement on Syncope. It was submitted by a consortium of over 60 physicians with expertise in transient loss of consciousness. The consortium has concerns that the Scientific Statement fails to adequately address long-standing clinical errors in syncope evaluation, provides imprecise definitions, omits important recent literature, and does not present the evaluation of syncope in full clinical context. If not revised, the Scientific Statement risks promoting inadequate patient care and potentially harmful legal standards for physicians.
International consensus recommendations on the management of 2010Klauditha AC
This document provides an update to international consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding (UGIB). A multidisciplinary group of 34 experts developed the recommendations using a standardized process. Key recommendations include:
1) Early risk stratification of patients using validated prognostic scales to identify high-risk cases requiring intervention.
2) Performing early endoscopy (within 24 hours) for risk assessment and therapeutic purposes.
3) Using endoscopic hemostasis for high-risk lesions while considering attempts to dislodge clots for underlying stigmata using pharmacological or combination treatments.
This document provides guidelines for hemodynamic support of sepsis in adult patients. It was developed by an international task force convened by the Society of Critical Care Medicine. The task force reviewed literature and drew on member expertise to develop consensus recommendations. Therapies for septic shock should aim to restore tissue perfusion and normalize cellular metabolism. Goals include maintaining blood pressure and organ function while identifying and treating infection. Therapies include fluid resuscitation, vasopressors, and inotropes, titrated based on parameters of global and regional perfusion.
CPG Management of pulmonary arterial hypertension (pah)Adel Ahmad
This document provides guidelines for the diagnosis and management of pulmonary arterial hypertension (PAH) in adults, children, and patients with congenital heart disease. It includes:
1. Classification of PAH and overview of pathogenesis
2. Recommendations on screening, diagnosis and evaluation of PAH through medical history, physical exams, imaging, blood tests and right heart catheterization.
3. Treatment guidelines including conventional treatments and PAH-specific drug therapies, with classifications of evidence and recommendations on monitoring treatment response.
It aims to provide evidence-based guidance to healthcare providers on the diagnosis and management of PAH according to international standards, tailored for the Malaysian healthcare system.
This document lists publications by Ari Gnanasakthy related to patient-reported outcomes in clinical trials and health economics evaluations. It includes 22 publications ranging from 2005 to 2010 related to establishing minimally important differences in patient-reported outcomes, developing guidance for collecting patient-reported data, evaluating the cost-effectiveness of drugs like valsartan and rivastigmine, and methods for conducting economic evaluations alongside multinational clinical trials. The publications indicate Gnanasakthy has extensive experience in analyzing patient-reported outcomes and health economics data from clinical trials.
This document provides guidelines on the diagnosis and management of syncope. It defines syncope and provides a brief overview of the pathophysiology. The document is divided into four parts: classification, epidemiology and prognosis; diagnosis; treatment; and special issues in evaluating patients with syncope. The guidelines aim to provide recommendations on diagnostic criteria, diagnostic workup, risk stratification, and determining when hospitalization is needed. Most recommendations are based on consensus expert opinion due to the lack of randomized controlled trials in this area.
Inter society consensus for the management of peripheral arterial disease (tasc)Jonathan Campos
This document summarizes the key findings of the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). It discusses the prevalence of peripheral arterial disease (PAD), finding that PAD affects approximately 3-10% of the general population but is asymptomatic in around 75% of cases. The ratio of asymptomatic to symptomatic PAD is estimated to be between 3:1 and 4:1. Symptomatic PAD presents mainly as intermittent claudication. The document also outlines the grading system used to rate the strength of recommendations.
This document summarizes the 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations from the six ILCOR task forces. It includes treatment recommendations from 21 systematic reviews covering topics in basic life support, advanced life support, pediatric life support, neonatal life support, education and teams, and first aid. The recommendations are based on an analysis of the evidence using the GRADE approach. Priority knowledge gaps for future research are also identified.
This document provides guidelines from the American Diabetes Association and European Association for the Study of Diabetes on the management of hyperglycemia in type 2 diabetes. It recommends a patient-centered approach that considers individual patient needs and preferences. Glycemic targets should aim to lower HbA1c levels to <7% but must be tailored based on factors like disease duration, comorbidities, and risks of hypoglycemia. The guidelines emphasize shared decision-making between clinicians and patients and choosing therapies based on each drug's efficacy, safety profile, and costs.
This document provides guidelines from the American Diabetes Association and European Association for the Study of Diabetes on the management of hyperglycemia in type 2 diabetes. It recommends a patient-centered approach that considers individual patient needs and preferences. Glycemic targets should aim to lower HbA1c levels to <7% but must be tailored based on factors like disease duration, comorbidities, and risks of hypoglycemia. The guidelines emphasize shared decision-making between clinicians and patients and choosing therapies based on each drug's efficacy, safety profile, and costs.
This document provides guidelines from the American Diabetes Association and European Association for the Study of Diabetes on the management of hyperglycemia in type 2 diabetes. It recommends a patient-centered approach that considers individual patient needs and preferences. Glycemic targets should aim to lower HbA1c levels to <7% but must be tailored based on factors like disease duration, comorbidities, and risks of hypoglycemia. The guidelines emphasize shared decision-making between clinicians and patients and choosing therapies based on each drug's efficacy, safety profile, costs and patient lifestyle.
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...Health Innovation Wessex
The AHSN Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Meeting for Hyper Polypharmacy Review, can be viewed here.
For more information about the polypharmacy programme, please visit https://www.ahsnnetwork.com/programmes/medicines/polypharmacy/